SCHEMBL152170

SCHEMBL152170

OCC1(CO)CC2CCC1C2

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.37
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18812547 0.87 ALOX5AP (0.36) ALOX5AP
Vinyl Ether SCHEMBL15090921 0.85 ALOX5AP (0.33) ALOX5AP
SCHEMBL34476571 0.82 ALOX5AP (0.31) ALOX5AP
SCHEMBL15103124 0.82 ALOX5AP (0.38) ALOX5APHSD11B1
SCHEMBL124615 0.76 GRIN2D (0.37) ALOX5AP
SCHEMBL28549300 0.76 ALOX5AP (0.33) ALOX5AP
SCHEMBL8653901 0.76 ALOX5AP (0.30) ALOX5AP
SCHEMBL21976124 0.76 ALOX5AP (0.30) ALOX5AP
SCHEMBL900016 0.74 ALOX5AP (0.39) ALOX5APHSD11B1
SCHEMBL3926739 0.74 HSD11B1 (0.49) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3822299-B1 BIO-BASED POLYCARBONATE ESTER RESIN FOR EYEGLASS FRAME SK CHEMICALS CO LTD (KR) 2026-02-18 EP claimed
US-12391795-B2 Polymerizable composition, and copolycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2025-08-19 US claimed
US-12269921-B2 Polycarbonate copolymer, method for preparing same, and composition comprising same Hanwha Solutions Corporation (KR) 2025-04-08 US claimed
US-20250019495-A1 POLYCARBONATE COPOLYMER, METHOD FOR PREPARING SAME, AND COMPOSITION COMPRISING SAME Hanwha Solutions Corporation (KR) 2025-01-16 US claimed
US-12162982-B2 Highly bio-based polycarbonate ester and method for producing same SK CHEMICALS CO., LTD. (KR) 2024-12-10 US claimed
CN-118930824-A Weather-resistant amorphous copolyester material and preparation method thereof 河南源宏高分子新材料有限公司 2024-11-12 CN claimed
US-20240166814-A1 POLYESTERAMIDE RESIN, MANUFACTURING METHOD OF THE SAME, AND BIAXIALLY STRETCHED FILM INCLUDING THE SAME SK CHEMICALS CO., LTD. (KR) 2024-05-23 US claimed
CN-112955492-B Gao Shengwu-based polycarbonates and process for producing the same SK化学公司 2023-09-08 CN claimed
EP-3872112-B1 HIGHLY BIO-BASED POLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME SK CHEMICALS CO LTD (KR) 2023-07-19 EP claimed
US-11479640-B2 Bio-based polycarbonate ester resin for eyeglass frame SK CHEMICALS CO., LTD. (KR) 2022-10-25 US claimed
US-20040067209-A1 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS 2004-04-08 US claimed
US-6623724-B2 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues APPLIED GENETICS INCORPORATED DERMATICS 2003-09-23 US claimed
US-20020141952-A1 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues APPLIED GENETICS INCORPORATED DERMATICS 2002-10-03 US claimed
US-6294585-B1 ADMINISTERING NORBORNANE DIOL/TRIOL OR NORBORNENE DIOL/TRIOL DERIVATIVES FOR INCREASING DIFFERENTIATION OF MAMMALIAN NEURONAL CELLS APPLIED GENETICS INCORPORATED DERMATICS 2001-09-25 US claimed
US-6267948-B1 ADMINISTERING TO MAMMALIAN SKIN, HAIR, WOOL OR FUR DERMATOLOGICAL FORMULATION CONTAINING MELANOGENESIS STIMULATING AGENT WHICH STIMULATES MELANOGENESIS IN MELANOCYTES AND HYDROXY ACID TO ENHANCE MELANOGENESIS APPLIED GENETICS INCORPORATED DERMATICS 2001-07-31 US claimed
US-5990177-A CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM CODON PHARMACEUTICALS, INC. (US) 1999-11-23 US claimed
WO-1998055085-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-12-10 WO claimed
US-5773661-A REACTION OF ALKALI METAL PHOSPHIDE WITH DISULFONIC ACID ESTEROF TRANS-2,3-NOBORNANEDIMETHANOL CELANESE INTERNATIONAL CORPORATION (US) 1998-06-30 US claimed
US-4782188-A Process for hydroformylation of unsaturated compounds using iron carbonyl catalysts THE DOW CHEMICAL COMPANY (US) 1988-11-01 US claimed
US-4753982-A STRENGTH, HEAT AND CORROSION RESISTANCE THE DOW CHEMICAL COMPANY (US) 1988-06-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020141952-A1 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues TYR, MITF, MC1R ALOX5AP 1076/4885HSD11B1 37/4885
US-20040067209-A1 Dermatological compositions and methods TYR, MITF, ALPG ALOX5AP 617/4885HSD11B1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.